Stock PRLD PRELUDE THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Market Closed - Nasdaq
Other stock markets
 21:00:00 13/05/2024 BST 		5-day change 1st Jan Change
3.8 USD +1.88% Intraday chart for Prelude Therapeutics Incorporated -0.78% -11.01%
05-07 Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-10 Bryant D. Lim to Serve as Principal Financial Officer and Principal Accounting Officer of Prelude Therapeutics Incorporated CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. News Prelude Therapeutics Incorporated
  5. Official Publications